|
|
|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
JANSSEN PHARMACEUTICA N.V.
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
C
|
|
INDICATIONS:
|
|
Candidiasis |
|
Candidiasis, vulvovaginal |
|
Coccidioidomycosis |
|
Cryptococcosis |
|
Infection, urinary tract, fungal |
|
Meningitis, fungal |
|
Paracoccidioidomycosis |
|
Pseudoallerscheriosis |
|
Tinea corporis |
|
Tinea cruris |
|
Tinea pedis |
|
Tinea versicolor |
| |
|
|
SIDE EFFECTS:
|
|
Blistering, burning, redness, skin rash, or other sign of skin irritation not present before therapy |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
|
|
ADULT DOSE:
|
|
Candidiasis, cutaneous or
Tinea corporis or
Tinea cruris or
Tinea pedis-
Topical, to the skin, two times a day, morning and evening.
Tinea versicolor -
Topical, to the skin, once a day. |
|
MAXIMUM ADULT DOSE:
|
|
|
|
PEDIATRIC DOSE:
|
|
Candidiasis, cutaneous or
Tinea corporis or
Tinea cruris or
Tinea pedis-
Topical, to the skin, two times a day, morning and evening.
Tinea versicolor -
Topical, to the skin, once a day. |
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
|
|
|
|
|
|